Immunoglobulin News and Research

RSS
Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

Immunity following COVID-19 vaccination and natural infection in India

Immunity following COVID-19 vaccination and natural infection in India

The immune response elicited by an inactivated SAR-CoV-2 vaccine

The immune response elicited by an inactivated SAR-CoV-2 vaccine

The autoantibody profile in COVID-19 patients with MIS-C

The autoantibody profile in COVID-19 patients with MIS-C

Chronological changes in SARS-CoV-2 immune responses after BNT162b2 vaccine

Chronological changes in SARS-CoV-2 immune responses after BNT162b2 vaccine

Mechanism of SARS-CoV-2 antibody transfer into breastmilk

Mechanism of SARS-CoV-2 antibody transfer into breastmilk

The impact of interventions and contact patterns on SARS-CoV-2 transmission

The impact of interventions and contact patterns on SARS-CoV-2 transmission

A measles-vectored COVID-19 vaccine induces strong immunity in animal model

A measles-vectored COVID-19 vaccine induces strong immunity in animal model

Pregnant women’s humoral response is dependent on SARS-CoV-2 strain

Pregnant women’s humoral response is dependent on SARS-CoV-2 strain

Researchers explain why decaying SARS-CoV-2 antibodies in blood are not a problem after vaccination

Researchers explain why decaying SARS-CoV-2 antibodies in blood are not a problem after vaccination

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

Adaptive immunity in patients infected with SARS-CoV-2 Δ382 Variant

Adaptive immunity in patients infected with SARS-CoV-2 Δ382 Variant

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Spike antibody durability in mRNA vaccinated individuals with or without prior SARS-CoV-2 infection

Spike antibody durability in mRNA vaccinated individuals with or without prior SARS-CoV-2 infection

SARS-CoV-2 neutralizing antibodies discovered in a 20-year-old human antibody library

SARS-CoV-2 neutralizing antibodies discovered in a 20-year-old human antibody library

Dutch study compares mRNA vaccines to vector-based vaccines for COVID-19

Dutch study compares mRNA vaccines to vector-based vaccines for COVID-19

End-stage renal disease negatively impacts COVID-19 vaccine response

End-stage renal disease negatively impacts COVID-19 vaccine response

Humoral and cell-mediated immunity six months post BNT162b2 vaccination

Humoral and cell-mediated immunity six months post BNT162b2 vaccination

Trends in SARS-CoV-2 seroprevalence in Massachusetts

Trends in SARS-CoV-2 seroprevalence in Massachusetts

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.